Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration
Tsaousidou M.K., Ouahchi K., Warner T.T., et al. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82 (2008) 510-515
Spastic paraplegia 5: Locus refinement, candidate gene analysis and clinical description
Klebe S., Durr A., Bouslam N., et al. Spastic paraplegia 5: Locus refinement, candidate gene analysis and clinical description. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 854-861
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia
Beetz C., Nygren A.O., Schickel J., et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67 (2006) 1926-1930
Stability and structure of model DNA triplexes and quadruplexes and their interactions with small ligands
Shafer R.H. Stability and structure of model DNA triplexes and quadruplexes and their interactions with small ligands. Prog Nucleic Acid Res Mol Biol 59 (1998) 55-94
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings
Barkhof F., Verrips A., Wesseling P., et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217 (2000) 869-876
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum
Stevanin G., Santorelli F.M., Azzedine H., et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39 (2007) 366-372
Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia
Simpson M.A., Cross H., Proukakis C., et al. Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73 (2003) 1147-1156